TY - JOUR
T1 - Six-minute walk distance in patients with chronic obstructive pulmonary disease
T2 - Which reference equations should we use?
AU - Andrianopoulos, Vasileios
AU - Holland, Anne E.
AU - Singh, Sally J.
AU - Franssen, Frits M.E.
AU - Pennings, Herman Jan
AU - Michels, Arent J.
AU - Smeenk, Frank W.J.M.
AU - Vogiatzis, Ioannis
AU - Wouters, Emiel F.M.
AU - Spruit, Martijn A.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - The use of different 6-min walk distance (6MWD) reference equations probably results in different predicted 6MWD reference values. We wished to investigate the impact of several 6MWD reference equations for adults in patients with chronic obstructive pulmonary disease (COPD) and factors accountable for different 6MWD% predicted values. Twenty-two 6MWD reference equations were applied to a data set of 2757 patients with COPD. The predicted 6MWD reference value of Troosters and colleagues was used as the point of reference. Four out of 21 remaining equations resulted in comparable 6MWD% predicted, 16 equations resulted in significantly higher 6MWD% predicted and 1 equation resulted in a significantly lower 6MWD% predicted. Similar differences in 6MWD% predicted were observed after stratification by sex. Body mass index and global initiative for chronic obstructive lung disease (GOLD) stage classification demonstrated varying results within and between the groups; 9 out of 21 equations resulted in comparable 6MWD% predicted in underweight patients but only 1 equation demonstrated comparable result in obese. Eight equations in GOLD I, whilst 5 out of 21 equations in GOLD IV resulted in comparable 6MWD% predicted. Existing 6MWD reference equations will give varying results. The choice of 6MWD reference equation should consider the consistency of 6-min walk test operating procedures and at least be specific for the country/region of origin.
AB - The use of different 6-min walk distance (6MWD) reference equations probably results in different predicted 6MWD reference values. We wished to investigate the impact of several 6MWD reference equations for adults in patients with chronic obstructive pulmonary disease (COPD) and factors accountable for different 6MWD% predicted values. Twenty-two 6MWD reference equations were applied to a data set of 2757 patients with COPD. The predicted 6MWD reference value of Troosters and colleagues was used as the point of reference. Four out of 21 remaining equations resulted in comparable 6MWD% predicted, 16 equations resulted in significantly higher 6MWD% predicted and 1 equation resulted in a significantly lower 6MWD% predicted. Similar differences in 6MWD% predicted were observed after stratification by sex. Body mass index and global initiative for chronic obstructive lung disease (GOLD) stage classification demonstrated varying results within and between the groups; 9 out of 21 equations resulted in comparable 6MWD% predicted in underweight patients but only 1 equation demonstrated comparable result in obese. Eight equations in GOLD I, whilst 5 out of 21 equations in GOLD IV resulted in comparable 6MWD% predicted. Existing 6MWD reference equations will give varying results. The choice of 6MWD reference equation should consider the consistency of 6-min walk test operating procedures and at least be specific for the country/region of origin.
KW - 6-min walk test
KW - 6MWD predicted values
KW - 6MWD reference equations
KW - COPD
KW - exercise capacity
UR - http://www.scopus.com/inward/record.url?scp=84930341854&partnerID=8YFLogxK
U2 - 10.1177/1479972315575201
DO - 10.1177/1479972315575201
M3 - Article
C2 - 25754856
AN - SCOPUS:84930341854
SN - 1479-9723
VL - 12
SP - 111
EP - 119
JO - Chronic Respiratory Disease
JF - Chronic Respiratory Disease
IS - 2
ER -